September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Arndt Vogel: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial
Apr 1, 2025, 11:25

Arndt Vogel: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial

Arndt Vogel, Managing Senior Consultant and a Professor in the Department of Gastroenterology, Hepatology, and Endocrinology at Hannover Medical School, shared an article by Daniel H. Palmer, et al. on X:

Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial.

Supports GemCap for R0 & lymph node-negative patients not eligible for mFOLFIRINOX.”

Arndt Vogel: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial

Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial.

Authors: Daniel H. Palmer, et al.

Arndt Vogel: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial